Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in inflammatory hand osteoarthritis
DRKS00000796Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in erosive osteoarthritis (EOA), polyosteoarthritis, sponsored by Charité – Universitätsmedizin Berlin. Started Mar 2015; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
erosive osteoarthritis (EOA)polyosteoarthritis
Beyond the preview
Go deeper on DRKS00000796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000796.